Diligence memo · auto-generated · as of July 2, 2026
Emerge Diagnostics, Inc
Emerge Diagnostics, Inc looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Emerge Diagnostics, Inc operates in Medical Devices, based in CARLSBAD.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Emerge Diagnostics, Inc has raised $12M in disclosed capital across 10 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2012-07-01.
Most recent recorded round closed around 2023-10-18.
Valuation (modeled)modeled
Provath models Emerge Diagnostics, Inc at approximately $688K (range $129K–$1.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.01× the median modeled value of Series A Medical Devices companies in 2022–2024 (13 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 2.7 yr ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round was 1.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 82% of Medical Devices peers (233 compared).
Modeled value ranks above 17% of those peers.
Closest niche peers: MBio Diagnostics, Inc., Vida Diagnostics Inc, New View Surgical, Inc., Thunder Road Surgical, Llc, Barsa Surgical Inc..
Peoplefiled
17 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.